Suspended NA INTERVENTIONAL 1-arm NCT06355843

Clinical Applications of Integrated PET/MR and PET/CT in the Diagnosis and Treatment of Prostate Cancer.

Sponsor: National Natural Science Foundation of China

Interventions 68Ga-PSMA

Updated 3 times since 2024 Last updated: Apr 3, 2024 Started: Apr 28, 2022 Primary completion: Sep 30, 2023 Completion: Mar 31, 2027

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Suspended

The 68Ge/68Ga generator is currently at the end of its lifespan. We are trying to purchase new equipment, which will take about half a year.

A NA clinical study on Pet-ct and Prostate Cancer, this trial is suspended. The trial is conducted by National Natural Science Foundation of China and has accumulated 3 data snapshots since 2022. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Suspended NA
Jul 2024 — Sep 2024 [monthly]

Suspended NA
May 2024 — Jul 2024 [monthly]

Suspended NA

First recorded

Apr 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Natural Science Foundation of China
The First Affiliated Hospital of Anhui Medical University

Data source: The First Affiliated Hospital of Anhui Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hefei, China